ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,401Medicare Part D Prescriptions Filled, Including Refills

Rank: 603 out of 2888

$431K Total Retail Price of All Prescriptions

Rank: 1002 out of 2888

401 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

42% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

6% of this provider’s 6,039 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,183 515 S3 1 4
METOPROLOL TARTRATE 269 189 2 10
METFORMIN HCL 262 177 3 8
SIMVASTATIN 254 202 4 2
CLONIDINE HCL 253 131 5 39
AMLODIPINE BESYLATE 242 164 6 5
GLYBURIDE 223 167 R 7 58
LOVASTATIN 195 155 8 41
CARISOPRODOL 173 30 R 9 82
FUROSEMIDE 171 137 10 6
OMEPRAZOLE 171 125 10 7
CRESTOR 151 144 12 20
HYDROCHLOROTHIAZIDE 150 119 13 15
NIFEDIPINE ER 130 94 14 76
POTASSIUM CHLORIDE 128 100 15 14
ACETAMINOPHEN-CODEINE 121 88 S3 16 147
LEVOTHYROXINE SODIUM 115 63 17 1
NEXIUM 103 54 18 19
ALLOPURINOL 102 82 19 37
LISINOPRIL 97 68 20 3
IBUPROFEN 96 63 21 87
TRIAMTERENE-HCTZ 94 70 22 63
NIFEDICAL XL 93 75 23 190
AMLODIPINE BESYLATE-BENAZEPRIL 91 78 24 67
SPIRONOLACTONE-HCTZ 91 64 24 266
DIOVAN HCT 86 22 26 61
ATORVASTATIN CALCIUM 79 57 27 9
ENALAPRIL MALEATE 71 68 28 49
TERAZOSIN HCL 68 68 29 152
CYCLOBENZAPRINE HCL 67 0 R 30 68
BYSTOLIC 66 47 31 99
BACLOFEN 66 15 31 121
WARFARIN SODIUM 66 58 31 22
VERAPAMIL ER 64 64 34 104
CLOPIDOGREL 64 47 34 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 43 36 28
ATENOLOL 61 51 37 25
PROMETHAZINE HCL 58 28 R 38 96
INSULIN SYRINGE 58 36 38 86
PHENYTOIN SODIUM EXTENDED 57 36 40 128
METOPROLOL SUCCINATE 57 48 40 11
AMITRIPTYLINE HCL 56 35 R 42 74
CAPTOPRIL 56 56 42 225
AMOXICILLIN 55 39 44 117
TAMSULOSIN HCL 53 53 45 29
PREDNISONE 51 19 46 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.